News

B virus case involves a man who had contact with wild monkeys, FDA approves therapy for teens living with HIV, FDA grants EUA for Flu A/B and COVID at-home testing, and more this week from Contagion.

Danjuma Adda on WHO's efforts against Hepatitis B and his call for global vaccination and treatment efforts.

New data demonstrates protection against new variants.

In a new federal survey, as many as 3 in 10 US adults have had the condition at some point.

Study addresses the racial and ethnic inequalities in TB incidence rates.

This annual event hosted by The Peggy Lillis Foundation (PLF) released their full agenda for advocacy and education that will be happen next week in Washington DC.

Study evaluates the outcomes of orthotopic liver transplantation of HIV-HBV coinfected patients.

New data shows young children are less likely to get diagnosed and get into the continuum of care including getting prescribed antiretroviral therapy (ART).

Water sampling reveals COVID-19 trends in homeless populations.

A large trial supports de-escalation from empiric, broad-spectrum antibiotic treatment for Enterobacterales bacteremia to a non-antipseudomonal agent.

The CDC's take on the importance of HIV awareness and testing among our youth.

The origins of the recent H5N1 (avian flu) case in Texas remain unknown, but a researcher offers insights into transmission between animals and humans, the likelihood of more cases, vaccine availability, and treatment.

A study evaluates the efficacy of nirmatrelvir-ritonavir in COVID-19 treatment across variants.

The company is going to submit their data to the FDA to seek approval for people within this age group.

A study on Italian vaccination rates and factors influencing Rotavirus vaccine acceptance.

Study shows GBP1 assists HCV in the replication and spread against antiviral expectations.

The federal agency has given the nod for dolutegravir/lamivudine (Dovato) for teens living with the virus and offers a novel option for patients.

Trial examines high-dose vs. standard-dose influenza vaccines.

As a potential alternative to antibiotic treatments, this investigational immunization offered protection for several years.

Evaluating the importance of RSV vaccination implications for adults.

Emergency use authorization for CorDx TyFast Flu A/B & COVID-19.

FDA approves Zevtera a new treatment option for bacterial infections, a comprehensive look at coccidioidomycosis, the impact of guidelines on reducing hospital-onset CDI incidence, and more this week from Contagion.

The case involves a man who had contact with wild monkeys.

Dr. Thomas Holland discusses the breakthrough in antibiotic development.

During the 2014-2016 African epidemic, investigational Ebola vaccines demonstrated safety and immunogenicity.

Alcohol Awareness Month highlights the need for action amidst the alcohol crisis in the US.

An FDA decision on the company’s mRNA-1345 is slated for May 12.

Examining the implications and challenges of coccidioidomycosis, histoplasmosis, and blastomycosis diagnosis during the COVID-19 pandemic.

The RSV prefusion F protein–based maternal vaccine phase 3 trial was halted due to the risk of this adverse event.

Zevtera approval shows efficacy and marks a new treatment option for bacterial infections including MRSA.